US jury says Lululemon infringed Nike shoe patent

Reuters
Yesterday
US jury says Lululemon infringed Nike shoe patent

By Blake Brittain

March 10 - A jury in New York federal court awarded Nike NKE.N $355,450 on Friday after finding that Lululemon's LULU.O athletic shoes violated the sneaker giant's patent rights, according to a verdict sheet made public on Monday.

The jury agreed with Nike that Lululemon's Chargefeel, Strongfeel and Blissfeel running and training shoes infringed a Nike patent covering innovations in sneaker structures. Jurors rejected similar claims related to a second Nike patent.

Nike had requested at least 5% of Lululemon's revenues from the shoes in damages, according to a court filing. A Lululemon spokesperson called the damages "nominal" and said the company was "very pleased with the outcome of the trial," though it intends to appeal the infringement ruling.

Spokespeople and attorneys for Nike did not immediately respond to requests for comment on the verdict.

Beaverton, Oregon-based Nike sued Lululemon in 2023 over the patents. Lululemon denied the allegations and argued that the patents were invalid.

Nike separately sued Lululemon in New York in 2022, alleging that Lululemon's Mirror Home Gym infringed Nike patents related to technology that allows users to target specific levels of exertion, compete with other users and record their performance.

That case is still ongoing.

The shoe patent case is Nike Inc v. Lululemon USA Inc, U.S. District Court for the Southern District of New York, No. 1:23-cv-00771.

For Nike: Michael Harris, Christopher Renk and Michael Sebba of Arnold & Porter Kaye Scholer

For Lululemon: Ali Razai, Jason White, and Brandon Smith of Morgan Lewis & Bockius

Read more:

Nike sues Lululemon, says footwear infringes patents

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10